Skip to content
PeptideAgent

Peptides for sleep: what the evidence shows

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

At a glance

DSIP (delta sleep-inducing peptide) is the only peptide marketed specifically for sleep; its human studies are small and decades old, and FDA's advisory committee voted against adding it to the 503A bulks list in July 2026. Tirzepatide is FDA approved for obstructive sleep apnea in adults with obesity.

Evidence: Strongest: Human RCT evidence3 peptides gradedVerified: Verified Sep 27, 2026

Do peptides help with sleep disorders?

3 peptides are graded for sleep disorders on this page. The strongest grade is human RCT evidence, for tirzepatide and DSIP (delta sleep-inducing peptide). Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.

What is the standard of care for sleep disorders?

Cognitive behavioral therapy for insomnia as first line; sleep hygiene; CPAP or oral appliances for obstructive sleep apnea; short term hypnotics when needed.

Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.

Which peptides have been studied for sleep disorders?

Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.

Peptides studied for Sleep disorders with evidence grades
PeptideEvidence for this useNote
TirzepatideEvidence: Human RCT evidenceFDA approved for moderate to severe obstructive sleep apnea in obesity (December 2024). [2]
DSIP (delta sleep-inducing peptide)Evidence: Human RCT evidenceSmall, older randomized placebo-controlled trials in insomnia with inconsistent results on sleep measures; PCAC voted against 503A listing in July 2026. [1]
EpitalonEvidence: Animal-only evidenceMarketed for melatonin and circadian effects; no indexed controlled trial. [1]

Cost and access

Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.

Frequently asked questions

Are there peptides for sleep?

DSIP (delta sleep-inducing peptide) is the only peptide marketed specifically for sleep, and its evidence is weak: small, older placebo-controlled trials in insomnia gave inconsistent results, and FDA's compounding advisory committee voted against adding it to the 503A bulks list in July 2026. Epitalon is marketed for melatonin and circadian effects without a controlled trial. The one peptide approved for a sleep disorder is tirzepatide (Zepbound), for moderate to severe obstructive sleep apnea in adults with obesity. [1] [2]

Is DSIP legal?

DSIP is not an FDA approved drug, and after the July 2026 advisory committee vote against listing it, it is not on the 503A bulks list, so a pharmacy has no federal basis to compound it from bulk. [1] [3]

Is any peptide FDA approved for sleep disorders?

Tirzepatide is an FDA approved drug, but an approval covers only the indications on that label, so check the label before assuming it applies to sleep disorders. The other peptides graded here are not FDA approved. [2] [3]

Has any peptide been tested in a randomized trial for sleep disorders?

Yes, for tirzepatide and DSIP (delta sleep-inducing peptide). Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [1] [2]

From the blog

Sources

  1. [1]FDA Pharmacy Compounding Advisory Committee meetings (July 2026 meeting on peptide nominations)FDA, 2026
  2. [2]FDA prescribing information for Zepbound (tirzepatide), via DailyMedFDA, 2025
  3. [3]Drugs@FDA: FDA-approved drugs databaseFDA